Organogenesis Holdings (ORGO) Net Cash Flow (2016 - 2025)
Historic Net Cash Flow for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to -$9.4 million.
- Organogenesis Holdings' Net Cash Flow fell 31045.18% to -$9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.6 million, marking a year-over-year decrease of 68363.68%. This contributed to the annual value of $31.8 million for FY2024, which is 293559.16% up from last year.
- Organogenesis Holdings' Net Cash Flow amounted to -$9.4 million in Q3 2025, which was down 31045.18% from -$36.8 million recorded in Q2 2025.
- In the past 5 years, Organogenesis Holdings' Net Cash Flow ranged from a high of $41.2 million in Q4 2024 and a low of -$36.8 million during Q2 2025
- Its 5-year average for Net Cash Flow is -$1.1 million, with a median of $93000.0 in 2023.
- As far as peak fluctuations go, Organogenesis Holdings' Net Cash Flow soared by 111612.9% in 2024, and later plummeted by 335366.93% in 2025.
- Over the past 5 years, Organogenesis Holdings' Net Cash Flow (Quarter) stood at $11.8 million in 2021, then plummeted by 140.08% to -$4.7 million in 2022, then skyrocketed by 216.53% to $5.5 million in 2023, then soared by 647.78% to $41.2 million in 2024, then plummeted by 122.71% to -$9.4 million in 2025.
- Its last three reported values are -$9.4 million in Q3 2025, -$36.8 million for Q2 2025, and -$25.6 million during Q1 2025.